Access Resources
3441 - 3450 of 7562 Results
Title
Year
- The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson’s Disease: A Feasibility Study2020RESTRICTEDTitle: The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson’s Disease: A Feasibility StudyJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: 4Start Page: 1515End Page: 1527Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-202188Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640973Citation Count: 20
-
RESTRICTEDTitle: The Effect of the COVID-19 Pandemic on People with Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: 4Start Page: 1365End Page: 1377Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-202249Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202249?id=journal-of-parkinsons-disease%2Fjpd202249Citation Count: 117
-
RESTRICTEDTitle: The Effects of Respiratory Training in Parkinson’s Disease: A Systematic ReviewJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: 4Start Page: 1315End Page: 1333Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202223Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/229513/229513.pdfCitation Count: 32
- The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson’s Disease2020RESTRICTEDTitle: The Impact of the COVID-19 Pandemic on Psychological Distress, Physical Activity, and Symptom Severity in Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: 4Start Page: 1355End Page: 1364Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202251Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202251?id=journal-of-parkinsons-disease%2Fjpd202251Citation Count: 92
- Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD)2020RESTRICTEDTitle: Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD)Journal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: 4Start Page: 1561End Page: 1569Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202090Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683040Citation Count: 4
- Intramolecular Povarov Reactions for the Synthesis of Chromenopyridine Fused 2-Pyridone Polyheterocycles Binding to α-Synuclein and Amyloid-β Fibrils2020RESTRICTEDTitle: Intramolecular Povarov Reactions for the Synthesis of Chromenopyridine Fused 2-Pyridone Polyheterocycles Binding to α-Synuclein and Amyloid-β FibrilsJournal Name: The Journal of Organic ChemistryPublisher: American Chemical Society (ACS)Vol: 85Issue #: 21Start Page: 14174End Page: 14189Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.joc.0c01699Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.joc.0c01699Citation Count: 16
- A Stearoyl–Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α‐Synuclein Mice2020RESTRICTEDTitle: A Stearoyl–Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α‐Synuclein MiceJournal Name: Annals of NeurologyPublisher: WileyVol: 89Issue #: 1Start Page: 74End Page: 90Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.25920Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25920Citation Count: 43
- Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease2020RESTRICTEDTitle: Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s diseaseJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 6Issue #: 43Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.aaz9360Best OA location URL: https://doi.org/10.1126/sciadv.aaz9360Citation Count: 178
- Reduced striatal vesicular monoamine transporter 2 in REM sleep behavior disorder: imaging prodromal parkinsonism2020RESTRICTEDTitle: Reduced striatal vesicular monoamine transporter 2 in REM sleep behavior disorder: imaging prodromal parkinsonismJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-74495-xBest OA location URL: https://www.nature.com/articles/s41598-020-74495-x.pdfCitation Count: 10
-
RESTRICTEDTitle: STN Versus GPi Deep Brain Stimulation for Action and Rest Tremor in Parkinson’s DiseaseJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2020.578615Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2020.578615/pdfCitation Count: 23